Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Investment bank Ladenburg Thalmann trimmed its price objective on Portland General Electric (POR) to $42.50 from $43.00 while maintaining a Sell stance, a move that comes as the utility navigates contested regulatory proceedings. The company has proposed a $10 million customer refund in its filing, but regulatory staff have countered with substanti…
Ocular Therapeutix (OCUL) looks like an asymmetric event trade. With AXPAXLI in large registrational programs, strong enrollment signals, rumors of renewed takeover interest from Sanofi, and stretched bearish sentiment, a positive SOL-1 readout could re-rate the stock. Risk is material - trial failure, financing needs, and reimbursement uncertainty…
Talen Energy (TLN) has just added ~2.9 GW of modern gas capacity, expanded digital infrastructure partnerships, and continues to generate healthy free cash flow. The market is fixated on short-term volatility; this trade buys the structural improvement at $340 with a stop at $320 and a $420 target over 180 trading days.
Canaccord Genuity has reaffirmed its Buy rating and $15.00 price target for Hillman Solutions Corp. (NASDAQ:HLMN) ahead of the company’s fourth-quarter results due February 17. The target implies roughly 51% upside from the recent share price of $9.92. Canaccord’s tenth round of customer checks across 51 U.S. locations found winter trends broadly i…
Canaccord Genuity has reiterated a Buy rating on Galaxy Digital (GLXY) with a $50 price target, implying roughly 127% upside from the current $21.98 share price. The firm pointed to the company’s roughly $3 billion of equity capital split across digital assets, data center operations and treasury/corporate, a prior DCF valuation of CoreWeave coloca…
Texas Instruments has reached an agreement to buy Silicon Laboratories for $7.5 billion, paying $231 per share in a transaction designed to bolster TI's position in wireless connectivity chips used in industrial and consumer equipment. The deal, advised exclusively by Goldman Sachs to TI, carries termination fees for both parties and is expected to…
Truist Securities lowered its price target on Varonis Systems to $34 from $42 while keeping a Buy rating, following the cybersecurity firm's quarter that beat revenue and ARR expectations but flagged a $30-50 million headwind to free cash flow and ARR contribution margin in fiscal 2026 tied to the end-of-life of its on-premises customer base.
Jefferies trimmed its price objective for BellRing Brands (BRBR) to $38.00 from $49.00 while retaining a Buy rating, citing intensifying competition and rising input costs in the ready-to-drink shake category. The stock trades well below its 52-week high and shows oversold technical readings. Recent results beat expectations, but management lowered…
BofA Securities lowered its price target on LENZ Therapeutics to $35 from $52 while keeping a Buy rating after the company reported preliminary fourth-quarter net product revenue for its presbyopia eye drop Vizz that beat consensus but signaled a slower market uptake. The brokerage trimmed peak sales and multi-year forecasts, citing earlier launch …
Canaccord Genuity increased its price target on Mercury Systems (MRCY) to $102.00 from $88.00 and maintained a Buy rating after the company reported fiscal second-quarter results that beat expectations on revenue, adjusted EPS and adjusted EBITDA. Mercury delivered $233 million in Q2/26 revenue and reported significant improvements in adjusted prof…
Jefferies reaffirmed a Hold rating on PepsiCo with a $164 price target, noting the company’s refreshed 2026 strategy emphasizing affordability, innovation and sharper execution. The firm highlighted that consumer reaction in the first half of the year will be decisive for the stock’s trajectory. Recent quarter results beat expectations and prompted…
H.C. Wainwright began coverage of Verastem (NASDAQ:VSTM) with a Buy rating and an $18.00 price target, highlighting the company’s KRAS G12D program and the MAPK CLAMP strategy. The firm emphasized VS-7375 as a potentially underappreciated asset, citing early clinical response rates and a mechanism that targets both active and inactive KRAS conforma…
DA Davidson raised its price objective on American Public Education (APEI) to $48 from $43 and kept a Buy rating, saying a recently passed funding bill removes a key overhang tied to the partial government shutdown. The firm pointed to the company’s military education leadership, profit gains at Rasmussen University, and AI-focused degree programs …
Bath & Body Works (BBWI) trades at a discounted multiple (P/E ~6.5, P/FCF ~4.8) while generating nearly $1.0B of free cash flow. The business has to repair a misfired adjacencies strategy and navigate litigation headlines, but a refocus on core fragrance and home categories plus expected margin recovery could produce double-digit total returns over…
Stifel reduced its 12-month price target on Intapp, Inc. (INTA) to $40 from $50 while retaining a Buy rating. The new target implies roughly 36% upside from the current share price of $29.31. The move follows guidance that suggests a modestly lighter second half and coincided with weakness across the software sector that pressured shares in after-h…
BofA Securities upgraded Omnicell (OMCL) from Neutral to Buy and increased its price target to $70 from $53, citing the upcoming launch of the Titan XT automated medication cabinet and the potential for an earnings revision cycle. The upgrade precedes Omnicell's earnings report scheduled for Thursday before market open and follows a string of analy…
BMO Capital has increased its 12-month price target on Merck to $135 from $130 and kept an Outperform rating after management flagged additional patent expirations that could extend Keytruda protection beyond 2028. The move reinforces prior upgrades and comes amid a wave of analyst target adjustments and company announcements, including dividend an…
H.C. Wainwright lowered its 12-month price target for Galaxy Digital to $40 from $45 while retaining a Buy rating, using an approximately 5.5x price-to-book multiple on a revised 2026 year-end book value estimate of $2.7 billion. The stock trades at $21.98, following a 30.7% drop over the prior week; Galaxy's market capitalization and P/E ratio sta…
BofA Securities upgraded Five Below from Underperform to Buy and raised its price target to $233 from $158, attributing the move to confidence in a recently assembled executive team and a strategic shift toward children and Millennial moms. The firm’s valuation is built on a 30x multiple of its fiscal 2028/calendar 2027 EPS estimate of $7.75. The s…
TD Cowen trimmed its 12-month price objective on Tyler Technologies to $600 from $650 but left its Buy rating intact as the company prepares to report quarterly results. The move follows a sharp share decline and comes amid analyst focus on SaaS bookings and Tyler's push into digital court-recording through a planned acquisition.
Needham has maintained a Buy rating on AudioCodes (AUDC) with a $12.50 price target after the company's fourth-quarter results. The target implies material upside from the stock's current trading level of $7.35, which is near its 52-week low and viewed as undervalued on Fair Value metrics. AudioCodes reported 22% year-over-year ARR growth to $79 mi…
Uber Technologies said it expects first-quarter adjusted earnings per share below analyst forecasts and reported fourth-quarter adjusted EPS that missed estimates. The company attributed rising trips and mobility growth to lower-cost ride options, while higher effective tax rates and accounting changes in the U.K. will damp reported margins. Leader…
Eli Lilly raised its 2026 earnings and sales targets, driven by strong consumer and international uptake of its obesity and diabetes medicines. The company forecast profit per share above analyst expectations and signaled that higher patient volumes should offset price concessions stemming from government pricing agreements.
Wells Fargo increased its 12-month price target on PepsiCo to $165 from $154 while retaining an Equal Weight rating. The move followed fourth-quarter 2025 results that were characterized as about in-line and came amid investor optimism after an earnings and revenue beat. Wells Fargo highlighted expectations for volume recovery in PepsiCo Foods Nort…
Wells Fargo increased its 12-month price target for Marathon Petroleum (MPC) to $217 from $213 and retained an Overweight rating after Marathon reported stronger-than-expected fourth-quarter 2025 results. The move reflects a combination of an EPS beat, unexpectedly high refining EBITDA and continued shareholder returns through buybacks and distribu…
